Corentec Co

Corentec Co EBIT Margin

The EBIT Margin (Operating Margin) of Corentec Co (104540.KQ) as of Nov 5, 2026 is 9.26 %. In the previous year, EBIT Margin (Operating Margin) was 2.96 % — a change of 212.91% (higher).

EBIT Margin

9.26 %

YoY

212.91%

Last updated:

EBIT Margin (Operating Margin) of Corentec Co is 2025 9.26 % . EBIT Margin (Operating Margin) of Corentec Co was 2024 2.96 % . It decreases by 212.91% higher compared to the previous year.

Corentec Co's operating (EBIT) margin stands at 9.3%, up from 6.3% several years earlier.

The Corentec Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-84.58 KRW
Jan 1, 2019
5.83 KRW
Jan 1, 2020
8.21 KRW
Jan 1, 2021
6.25 KRW
Jan 1, 2022
11.73 KRW
Jan 1, 2023
11.29 KRW
Jan 1, 2024
2.96 KRW
Jan 1, 2025
9.26 KRW
The Corentec Co EBIT Margin history
YEAREBIT MarginYoY
9.26 %+212.91%
2.96 %-73.79%
11.29 %-3.77%
11.73 %+87.69%
6.25 %-23.82%
8.21 %+40.79%
5.83 %-106.89%
-84.58 %+335.61%
-19.42 %-1,712.36%
1.20 %-62.42%
3.20 %-529.35%
-0.75 %-1,398.89%
0.06 %-18.96%
0.07 %-152.95%
-0.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

EBIT Margin (Operating Margin) of Corentec Co is 9.26 % in 2025.

EBIT Margin (Operating Margin) of Corentec Co changed from 2.96 % to 9.26 %, representing a 212.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Corentec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Corentec Co

All Key Metrics — Corentec Co